Compare Robinhood Markets, Inc. (HOOD) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Robinhood Markets, Inc. vs ResMed Inc. — how do they compare? Robinhood Markets, Inc. trades at $107.21 (market cap $89.13B), while ResMed Inc. trades at $197.45 (market cap $28.81B). The key difference: Robinhood Markets, Inc. is far larger — about 3.1× ResMed Inc.'s market cap, and ResMed Inc. pays a 1.21% dividend while Robinhood Markets, Inc. pays none. Which is the better fit depends on your goals.
| HOOD | RMD | |
|---|---|---|
Market Cap | $89.13B | $28.81B |
Sector | Technology | Health |
52-Week High | $152.46 | $293.73 |
52-Week Low | $65.16 | $182.82 |
Enterprise Value | $90.33B | $27.99B |
Dividend Yield | — | 1.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Robinhood Markets (HOOD) trades at $106.36, up 6.4% over 24 hours, with technical indicators showing a bearish trend near resistance at $106. The company reported strong 2025 results with $4.47B revenue and $1.88B net income, though Q1 2026 EPS missed expectations. Recent news highlights expansion into blockchain infrastructure and institutional stake changes.
Outlook remains mixed: analyst consensus is bullish with a $118.07 price target, but risks include earnings volatility and competitive pressures. The stock's high P/E of 48.19 suggests premium valuation, requiring sustained growth to justify current levels amid bearish technical signals.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
